Annex

Annexes I, II, III and VI to Directive 2006/141/EC are amended as follows:

1. (1)

   Annex I is amended as follows:

   1. (a)

      point 2.1 is amended as follows:

      1. (i)

         the title is replaced by the following:

         ‘2.1.

         Infant formulae manufactured from cows’ milk or goats’ milk proteins ’;

      2. (ii)

         footnote 1 is replaced by the following:

         ‘(¹)

         Infant formulae manufactured from cows’ milk or goats’ milk protein with a protein content between the minimum and 0,5 g/100 kJ (2 g/100 kcal) shall be in accordance with the second subparagraph of Article 7(1).’;

   2. (b)

      in point 2.3, the title is replaced by the following:

      ‘2.3.

      Infant formulae manufactured from soya protein isolates, alone or in a mixture with cows’ milk or goats’ milk proteins ’;

   3. (c)

      in point 10.1, the title is replaced by the following:

      ‘10.1.

      Infant formulae manufactured from cows’ milk or goats’ milk proteins or protein hydrolysates ’;

   4. (d)

      in point 10.2, the title is replaced by the following:

      ‘10.2.

      Infant formulae manufactured from soya protein isolates, alone or in a mixture with cows’ milk or goats’ milk proteins ’;

2. (2)

   Annex II is amended as follows:

   1. (a)

      in point 2.1, the title is replaced by the following:

      ‘2.1.

      Follow-on formulae manufactured from cows’ milk or goats’ milk proteins ’;

   2. (b)

      in point 2.2, the table is replaced by the following:

      Follow-on formulae manufactured from protein hydrolysates with a protein content between the minimum and 0,56 g/100 kJ (2,25 g/100 kcal) shall be in accordance with the second subparagraph of Article 7(2).’
      ‘Minimumf1	Maximum
      0,45 g/100 kJ (1,8 g/100 kcal)	0,8 g/100 kJ (3,5 g/100 kcal)

   3. (c)

      in point 2.3, the title is replaced by the following:

      ‘2.3.

      Follow-on formulae manufactured from soya protein isolates, alone or in a mixture with cows’ milk or goats’ milk proteins ’;

   4. (d)

      in point 8.1, the title is replaced by the following:

      ‘8.1.

      Follow-on formulae manufactured from cows’ milk or goats’ milk proteins or protein hydrolysates ’;

   5. (e)

      in point 8.2, the title is replaced by the following:

      ‘8.2.

      Follow-on formulae manufactured from soya protein isolates, alone or in a mixture with cows’ milk or goats’ milk proteins ’;

3. (3)

   in point 3 of Annex III, footnote 1 is replaced by the following:

   ‘(¹)

   L-arginine and its hydrochloride shall only be used in the manufacture of infant formulae referred to in the third subparagraph of Article 7(1) and follow-on formulae referred to in the second subparagraph of Article 7(2).’;

4. (4)

   the title of Annex VI is replaced by the following:

   ‘ Specification for the protein content and source and the processing of protein used in the manufacture of infant formulae and follow-on formulae with a protein content less than 0,56 g/100 kJ (2,25 g/100 kcal) manufactured from hydrolysates of whey proteins derived from cows’ milk protein ’.